Predictive value of elevated neutrophil-lymphocyte ratio for left ventricular systolic dysfunction in patients with

Adem Bekler1, Gokhan Erbag2, Hacer Sen3

  • 1Adem Bekler, MD, Department of Cardiology, Canakkale Onsekiz Mart University, School of Medicine, Canakkale/Turkey.

Insights

A high neutrophil-lymphocyte ratio (NLR) predicts left ventricular systolic dysfunction (LVSD) in non ST-elevated acute coronary syndrome (NSTE-ACS) patients. Admission NLR >3.2 identifies high-risk individuals needing tailored treatment strategies.

Area of Science:

  • Cardiology
  • Hematology
  • Biomarkers

Background:

  • Non ST-elevated acute coronary syndrome (NSTE-ACS) is a common cardiac emergency.
  • Left ventricular systolic dysfunction (LVSD) is a significant complication impacting patient outcomes.
  • Identifying early predictors of LVSD in NSTE-ACS is crucial for timely intervention.

Purpose of the Study:

  • To investigate the predictive value of the neutrophil-lymphocyte ratio (NLR) for LVSD in NSTE-ACS patients.
  • To determine if admission NLR can identify patients at higher risk of developing LVSD.

Main Methods:

  • A cohort of 405 NSTE-ACS patients was analyzed.
  • Patients were stratified into tertiles based on admission NLR values (low ≤1.81, medium 1.81-3.2, high >3.2).
  • Multivariate analyses were performed to identify independent predictors of systolic dysfunction.

Main Results:

  • The high NLR group (NLR >3.2) exhibited older age, higher rates of diabetes and NSTEMI, and lower left ventricular ejection fraction (LVEF).
  • NLR was negatively correlated with LVEF.
  • An NLR >3.2 and age ≥70 were independent predictors of systolic dysfunction.

Conclusions:

  • An admission NLR >3.2 is a valuable predictor of LVSD in NSTE-ACS patients.
  • Utilizing NLR on admission can aid in identifying high-risk patients.
  • This may guide the selection of appropriate treatment strategies for these patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
468
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
782
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
791